Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Levinsohn Ross

2. Date of Event Requiring Statement (MM/DD/YYYY) 8/26/2020

3. Issuer Name and Ticker or Trading Symbol

theMaven, Inc. [MVEN]

(Last) (First) (Middle)

225 LIBERTY STREET, 27TH FLOOR

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Executive Officer /

(Street)

NEW YORK, NY 10281

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	245434	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option to purchase	⁽¹⁾	4/10/2029	Common Stock	532004	$0.46	D
Option to purchase	⁽²⁾	6/19/2029	Common Stock	2000000	$0.42	D
Option to purchase	⁽³⁾	9/16/2029	Common Stock	2000000	$0.81	D

Explanation of Responses:
(1)	The option shall be subject to vesting (i) based on the achievement by the Issuer of stock price and liquidity targets and (ii) a concurrent 36-month vesting period with a 12-month cliff. The ability to exercise is subject to both: i) vesting conditions (listed in the preceding sentence) and ii) the Issuer's Board of Directors approving a requisite increase in authorized shares of common stock, after the date the grant was issued, that would apply to this grant.
(2)	1/3 vest after 1 year. Balance vests monthly over next 2 years. Grant is pending an amendment to the Issuer's Certificate of Incorporation increasing the number of authorized shares of Common Stock to allow for exercise of the grant.
(3)	1/3 vest after 1 year. Balance vests monthly over next 2 years. Grant is pending an amendment to the Issuer's Certificate of Incorporation increasing the number of authorized shares of Common Stock to allow for exercise of the grant.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Levinsohn Ross 225 LIBERTY STREET, 27TH FLOOR NEW YORK, NY 10281	X		Chief Executive Officer

Signatures
/s/ Ross Levinsohn		12/29/2020
^**Signature of Reporting Person		Date